136 related articles for article (PubMed ID: 7150332)
41. UDP-glucuronyltransferase activity toward harmol in human liver and human fetal liver cells in culture.
Tan TM; Sit KH; Wong KP
Anal Biochem; 1990 Feb; 185(1):44-50. PubMed ID: 2111643
[TBL] [Abstract][Full Text] [Related]
42. UDP glucuronyltransferase and phenolsulfotransferase from rat liver in vivo and in vitro. Characterization of conjugation and biliary excretion of harmol in vivo and in the perfused liver.
Mulder GJ; Hayen-Keulemans K; Sluiter NE
Biochem Pharmacol; 1975 Jan; 24(1):103-7. PubMed ID: 804900
[No Abstract] [Full Text] [Related]
43. Sulfation and glucuronidation of acetaminophen by cultured hepatocytes reproducing in vivo sex-differences in conjugation on Matrigel and type 1 collagen.
Kane RE; Tector J; Brems JJ; Li A; Kaminski D
In Vitro Cell Dev Biol; 1991 Dec; 27A(12):953-60. PubMed ID: 1757400
[TBL] [Abstract][Full Text] [Related]
44. Intestinal biotransformation of harmol and 1-naphthol in the rat. Further evidence of dose-dependent phase-II conjugation in situ.
Goon D; Klaassen CD
Drug Metab Dispos; 1991; 19(2):340-7. PubMed ID: 1676634
[TBL] [Abstract][Full Text] [Related]
45. Effects of molybdate on the sulfation of harmol and alpha-naphthol.
Boles JW; Klaassen CD
Toxicology; 1998 May; 127(1-3):121-7. PubMed ID: 9699799
[TBL] [Abstract][Full Text] [Related]
46. Phenol sulphotransferase and uridine diphosphate glucuronyltransferase from rat liver in vivo and vitro. 2,6-Dichloro-4-nitrophenol as selective inhibitor of sulphation.
Mulder GJ; Scholtens E
Biochem J; 1977 Sep; 165(3):553-9. PubMed ID: 411489
[TBL] [Abstract][Full Text] [Related]
47. The role of sulfation in the metabolic activation of N-hydroxy-4'-fluoro-4-acetylaminobiphenyl.
van de Poll ML; Tijdens RB; Vondrácek P; Bruins AP; Meijer DK; Meerman JH
Carcinogenesis; 1989 Dec; 10(12):2285-91. PubMed ID: 2480190
[TBL] [Abstract][Full Text] [Related]
48. Xenobiotic metabolism by isolated rat small intestinal cells.
Grafström R; Moldéus P; Andersson B; Orrenius S
Med Biol; 1979 Oct; 57(5):287-93. PubMed ID: 522515
[TBL] [Abstract][Full Text] [Related]
49. Sex differences in sulfation and glucuronidation of phenol, 4-nitrophenol and N-hydroxy-2-acetylaminofluorene in the rat in vivo.
Meerman JH; Nijland C; Mulder GJ
Biochem Pharmacol; 1987 Aug; 36(16):2605-8. PubMed ID: 3606659
[TBL] [Abstract][Full Text] [Related]
50. Effect of 3-methylcholanthrene pretreatment on glucuronidation and sulfation in perfused rat liver.
Hamada N; Gessner T
Drug Metab Dispos; 1975; 3(5):407-16. PubMed ID: 241622
[TBL] [Abstract][Full Text] [Related]
51. Differential effects of phenobarbitone and 3-methylcholanthrene induction on the hepatic microsomal metabolism of the beta-carbolines harmine and harmol.
Tweedie DJ; Burke MD
Biochem Pharmacol; 1983 Feb; 32(4):653-63. PubMed ID: 6830628
[No Abstract] [Full Text] [Related]
52. Systematic studies of sulfation and glucuronidation of 12 flavonoids in the mouse liver S9 fraction reveal both unique and shared positional preferences.
Tang L; Zhou J; Yang CH; Xia BJ; Hu M; Liu ZQ
J Agric Food Chem; 2012 Mar; 60(12):3223-33. PubMed ID: 22352802
[TBL] [Abstract][Full Text] [Related]
53. Secondary bioenergetic hypoxia. Inhibition of sulfation and glucuronidation reactions in isolated hepatocytes at low O2 concentration.
Aw TY; Jones DP
J Biol Chem; 1982 Aug; 257(15):8997-9004. PubMed ID: 6284753
[TBL] [Abstract][Full Text] [Related]
54. Metabolism of the beta-carbolines, harmine and harmol, by liver microsomes from phenobarbitone- or 3-methylcholanthrene-treated mice. Identification and quantitation of two novel harmine metabolites.
Tweedie DJ; Burke MD
Drug Metab Dispos; 1987; 15(1):74-81. PubMed ID: 2881762
[TBL] [Abstract][Full Text] [Related]
55. Effect of erythrocyte binding on elimination of harmol by the isolated perfused rat liver.
Morgan DJ; Guttmann A; Watson RG; Ghabrial H; Elliott SL; Smallwood RA
J Pharm Sci; 1996 Jan; 85(1):40-4. PubMed ID: 8926581
[TBL] [Abstract][Full Text] [Related]
56. Effect of calcium ions on ethanol oxidation and drug glucuronidation in isolated hepatocytes.
Andersson B; Jones DP; Orrenius S
Biochem J; 1979 Dec; 184(3):709-11. PubMed ID: 540060
[TBL] [Abstract][Full Text] [Related]
57. Competition between two enzymes for substrate removal in liver: modulating effects due to substrate recruitment of hepatocyte activity.
Morris ME; Pang KS
J Pharmacokinet Biopharm; 1987 Oct; 15(5):473-96. PubMed ID: 3694493
[TBL] [Abstract][Full Text] [Related]
58. Metabolite kinetics: formation of acetaminophen from deuterated and nondeuterated phenacetin and acetanilide on acetaminophen sulfation kinetics in the perfused rat liver preparation.
Pang KS; Waller L; Horning MG; Chan KK
J Pharmacol Exp Ther; 1982 Jul; 222(1):14-9. PubMed ID: 7086695
[TBL] [Abstract][Full Text] [Related]
59. Carrier-mediated entry of 4-methylumbelliferyl sulfate: characterization by the multiple-indicator dilution technique in perfused rat liver.
Chiba M; Schwab AJ; Goresky CA; Pang KS
Hepatology; 1998 Jan; 27(1):134-46. PubMed ID: 9425929
[TBL] [Abstract][Full Text] [Related]
60. Nonlinear protein binding and enzyme heterogeneity: effects on hepatic drug removal.
Xu X; Selick P; Pang KS
J Pharmacokinet Biopharm; 1993 Feb; 21(1):43-74. PubMed ID: 8410683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
